SciELO - Scientific Electronic Library Online

 
vol.60 issue4Prevalence and predictive factors of urinary retention assessed by ultrasound in the immediate post-anesthetic periodEvaluating the cost of drugs used in the outpatient treatment of chronic pain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

Share


Revista Brasileira de Anestesiologia

Print version ISSN 0034-7094

Rev. Bras. Anestesiol. vol.60 no.4 Campinas July/Aug. 2010

http://dx.doi.org/10.1590/S0034-70942010000400006 

SCIENTIFIC ARTICLE

 

Phenylephrine for blood pressure control in elective cesarean section: therapeutic versus prophylactic doses

 

 

José Francisco Nunes Pereira das Neves, TSAI; Giovani Alves Monteiro, TSAII; João Rosa de AlmeidaIII; Roberto Silva Sant'AnnaIII; Hellen Bedim Bonin IV; Carlos Furtado MacedoIV

ICo-responsible for CET/SBA of Universidade Federal de Juiz de Fora. Coordinator of the Anesthesiology Department of Hospital Monte Sinai, Juiz de Fora, MG
IICo-responsible for CET/SBA da Universidade Federal de Juiz de Fora. Anesthesiologist of Hospital Monte Sinai, Juiz de Fora, MG
IIIAnesthesiologist of Hospital Monte Sinai, Juiz de Fora, MG
IVR-III of CET/SBA da Universidade Federal de Juiz de Fora, MG

Correspondence to

 

 


SUMMARY

BACKGROUND AND OBJECTIVES: Spinal block is commonly used in cesarean sections and, if some prophylactic measures are not taken, the incidence of hypotension is higher than 80%. The objective of this study was to compare the efficacy of the administration of therapeutic or prophylactic doses of phenylephrine to maintain blood pressure in patients undergoing spinal block for elective cesarean section.
METHODS: One hundred and twenty gravidas undergoing elective cesarean sections under spinal block, randomly divided in three equal groups according to the regimen of phenylephrine administered, were included in this study. In Group 1, continuous infusion of phenylephrine, using an infusion pump at 0.15 µg.kg-1.min-1 was administered after the spinal block. In Group 2, a single dose of prophylactic phenylephrine 50 µg was administered after the spinal block, and Group 3 received a single dose of phenylephrine 50 µg in case of hypotension, which was defined as a drop in SBP and/or DBP of up to 20% of baseline levels. The incidence of hypotension, nausea, and vomiting as well as the Apgar score were evaluated.
RESULTS: The incidence of hypotension was significantly greater in Group 3, affecting 85% of the gravidas. In Groups 1 and 2 hypotension was seen in 17.5% and 32.5% of the cases respectively (p < 0.001). The incidence of nausea was much higher in Group 3 affecting 40% of the patients while in Groups 1 and 2 it was 10% and 15% respectively which was statistically significant.
CONCLUSIONS: According to the methodology used, this study showed that prophylactic continuous infusion of phenylephrine initiated immediately after the spinal block for cesarean section is more effective in reducing the incidence of hypotension and maternal and fetal side effects.

Keywords: ANESTHESIA, Obstetric; COMPLICATIONS: hypotension; DRUGS: phenylephrine; SURGERY, Obstetric: cesarean section.


 

 

INTRODUCTION

Spinal block is commonly used in cesarean sections due to the fast onset of action, sensorial and motor blockade, as well as a reduction in the risk of toxicity of the local anesthetic. Maternal hypotension is the most common intraoperative complication of this anesthetic technique, with an incidence higher than 80% if prophylactic measures are not taken 1-8.

Preventive measures include the administration of fluids, correct positioning of the patient with decompression of abdominal vessels, and the use of vasopressors3-5,9. The use of prophylactic vasopressors immediately after the spinal block seems to be more effective in reducing the incidence of hypotension10.

Historically, ephedrine was the vasopressor recommended in obstetrics, but evidence suggest that ephedrine causes a reduction in fetal pH and base excess, although without affecting the Apgar index, when compared to other vasopressors such as phenylephrine and metaraminol 8,11.

The objective of the present study was to investigate the efficacy of phenylephrine when administered therapeutically and prophylactically for the maintenance of blood pressure in patients undergoing spinal block for elective cesarean section.

 

METHODS

After approval by the Ethics on Research Committee and signing of the informed consent, 120 gravidas were selected for this prospective, randomized, double blind study.

Inclusion criteria were as follows: physical status ASA I, term pregnancy of a single fetus, and indication for elective cesarean section. Exclusion criteria were: refusal of the patient to participate in the study, history of hypertension or pregnancy-induced hypertension, cardiovascular or cerebro-vascular disease, fetal abnormalities, history of hypersensitivity to the drugs used in the study, and contraindications to spinal block. Patients were monitored with continuous electrocardiogram, non-invasive blood pressure, and pulse oximeter using a DX 2010 monitoring device. Venoclysis was performed with an 18G catheter. Patients were placed in dorsal decubitus dislocating the uterus to the left for a few minutes, with blood pressure and heart rate recorded three times, with a three-minute interval between measurements to obtain mean baseline levels. With the patient in the sitting position, spinal block was performed with a 27G Quincke needle in the L3-L4 space, and a solution containing 10 mg of hyperbaric 0.5% bupivacaine and 100 µg of morphine, at a rate of 1 mL every 15 seconds, was administered. Afterwards, with the patient in dorsal decubitus, a pad was placed under the right flank to dislocate the uterus to the left, and the infusion of Ringer's lactate at a rate of 10 mL.kg-1 was instituted. Patients were randomly distributed in three groups, using sequential sealed envelopes containing random computer-generated numbers. The result of the distribution was not revealed, and it was not known by patients or physicians responsible for collection and analysis of the data. The size of the study population was based on prior studies. The groups were composed of 40 patients each. Phenylephrine was used in three different administration regimens:

• Group 1: Continuous intravenous infusion of phenylephrine, using a one-channel "Baxter" volumetric infusion pump, at 0.15 µg.kg-1.min-1, which was started immediately after the spinal block.

• Group 2: A single dose of phenylephrine, 50 µg IV, administered immediately after the spinal block.

• Group 3: A single dose on phenylephrine, 50 µg IV, administered in case of hypotension, defined as a fall in systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) of up to 20% of mean baseline levels.

In all groups, the "Baxter" volumetric infusion pump was connected. In Group 1, a solution containing 10 mL of NS with 10 mg of phenylephrine (100 µg.mL-1) was prepared; in Groups 2 and 3, a solution containing 100 mL of NS was prepared. Only the anesthesiologist responsible for the anesthesia was aware of which group the patient belonged to and which medications were being administered. This anesthesiologist was not involved in data collection or analysis of the results.

In all groups, the use of a bolus of 30 µg of phenylephrine IV repeated every 2 minutes, in case of a drop in blood pressure greater than 20%, not controlled with the therapeutic regimen used, was allowed.

Episodes of hypotension defined as a drop in SBP and/ or DBP greater than 20% were recorded. Reactive hypertension was characterized as a blood pressure 20% greater than baseline mean levels after the use of the vasopressor. Heart rate lower than 50 bpm characterized bradycardia, and when associated with hypotension it was treated with 0.5 mg of atropine IV. Nausea, vomiting, and the need of rescue doses of phenylephrine were recorded.

Apgar scores in the first and fifth minutes of the newborns were evaluated.

The results obtained underwent statistical analysis using the software SPSS version 14.0. To analyze the equality of the initial anthropometric conditions, Analysis of Variance (ANOVA) followed by the Tukey Post Hoc test were used. The significance of the association among the three groups and the categorical parameters were determined by the Chisquare test. The Kruskal-Wallis test followed by the Mann-Whitney test was used to determine the significance of the differences in Apgar scores among the three groups. Levels of p < 0.05 were considered significant.

 

RESULTS

Statistical differences in age, weight, height, initial systolic blood pressure (SBP), and initial heart rate (HR) were not observed among the three groups, and although a statistically significant difference was observed in initial diastolic blood pressure (DBP) (p < 0.05) among the three groups it was not clinically relevant (Table I).

As for hypotension, it was observed in 17.5% of the cases in Group 1, and in 32.5% in Group 2. The incidence of hypotension was much higher in Group 3 than in Groups 1 and 2, affecting 85% of the patients, which was statistically significant (p < 0.001).

The number of patients who required rescue doses of phenylephrine was also statistically significant among the groups (p < 0.01), affecting 12.5% of the patients in Group 1, 30% in Group 2, and 70% in Group 3.

Only one patient in Group 1 developed reactive hypertension, which was adequately treated with discontinuation of the infusion of phenylephrine. Bradycardia was seen in one patient in Group 2, which did not require treatment, since it was transitory and it was not associated with hypotension.

The incidence of nausea was greater in Group 3, affecting 40% of the patients, while in Groups 1 and 2 it had an incidence of 10% and 15%, respectively, which was statistically significant (p = 0.02). Statistically significant differences in the incidence of vomiting were not observed among the groups (Table II, Chart 1).

 

 

Apgar scores in the first minute showed a higher proportion of newborns with values equal to or lower than 8 in Group 3 (40%) than in Groups 1 and 2, which was statistically significant (p = 0.01). A statistically significant difference in the Apgar in the first minute was not observed between Groups 1 and 2. The Apgar in the fifth minute did not show differences among the three groups (Table III).

 

DISCUSSION

Hypotension after spinal block for cesarean section is a common clinical problem, with an increase in maternal and fetal morbidity1,2,5,9.

The sympathetic blockade causes a reduction in blood pressure as a result of the fall in systemic vascular resistance with a reduction in venous return leading to a fall in cardiac output and occasionally heart rate5.

The fall in blood pressure has immediate maternal and fetal repercussions. Maternal symptoms include nausea, vomiting, and feeling of impending doom due to a reduction in cerebral reperfusion, and inadequate treatment of hypotension can lead to loss of consciousness and cardiac arrest. The fetus is affected immediately because uterine flow depends on maternal blood pressure2.

An isolated method that prevents hypotension during cesarean section does not exist12. The use of crystalloids before spinal block is practically ineffective because, despite the previous volume expansion, 85% of the patients develop hypotension. This happens because crystalloids are rapidly redistributed and induce the secretion of natriuretic peptide, leading to peripheral vasodilation and extravasation of fluid to the third space9. Administration after the spinal block can be useful because it increases the intravascular fluid during the period of maximal risk of hypotension and facilitates the rapid circulation of the vasopressor2.

It is important to fully understand the hemodynamic responses to choose properly the vasopressor and clinical dose14. The ideal vasopressor should have a low cost, be readily available, have a fast onset of action, be reliable, and have favorable effects in maternal heart rate, fetus, and placental perfusion2. Phenylephrine is considered the first drug of choice and its efficacy and safety during cesarean sections have been thoroughly investigated12. This is a synthetic non-catecholamine drug, but its function is similar to that of norepinephrine with direct action in the ]1-adrenergic receptor2. It promotes vasoconstriction especially arterial by increasing systemic vascular resistance, and therefore increasing preload2,14.

In the present study, the doses chosen were the minimal for direct intravenous administration (50 to 200 µg) and continuous infusion (0.15 to 0.75 µg.kg-1.min-1)15, while the optimal dose has yet to be determined1. The rescue dose (30 µg) was the same used in another study12.

The group that received conventional phenylephrine showed an incidence of hypotension of 85%. In the groups in which the drug was used prophylactically, the incidence of hypotension, collateral effects, and the need of rescue doses were lower. The best results were seen in the continuous infusion group.

The optimal dose of phenylephrine for the control of blood pressure during cesarean section has not been determined yet. It has been observed that, even when phenylephrine was used in high doses (above 2,000 µg), fetal deleterious effects measured by the Apgar score and arterial blood gases of umbilical cord blood were not observed5,8. This occurs because the contractile response of the uterine artery to drugs, such as ephedrine and phenylephrine, is attenuated during pregnancy due to an increase in the activity of nitrous oxide16. Low pH and base excess are related with the time between the surgical incision and fetal extraction8.

As for collateral effects, a higher incidence of nausea and vomiting was seen in the therapeutic group. Although several factors are related to the etiology of nausea and vomiting during cesarean section under regional block, hypotension is the most important, especially before delivery. Nausea and vomiting have an incidence of 4% in patients in whom systolic pressure is maintained at baseline levels, and it ranges from 16 to 40% in patients whose blood pressure is lower than or equal to 80 to 90% of pre-anesthetic levels1.

Evaluation of Apgar scores in the first minute showed a significant statistical difference between the therapeutic and prophylactic groups, which emphasizes the importance of monitoring blood pressure for maintenance of uteroplacental perfusion. In the present study, we decided not to performed analysis of umbilical cord blood gases because the difference of time between blood collection and analysis can change values and influence the results, and low pH levels and base excess are related with the time between the surgical incision and fetal extraction8.

According to the methodology used, the study shows that continuous infusion of prophylactic phenylephrine initiated immediately after the spinal block is more effective in reducing the incidence of hypotension and maternal and fetal side effects.

 

REFERENCES

01. Tanaka M, Balki M, Parkes RK et al. - ED95 of phenylephrine to prevent spinal-induced hypotension and/or nausea at elective cesarean delivery. Int J Obstet Anesth, 2009;18:125-130.         [ Links ]

02. Macarthur A, Riley ET - Obstetric anesthesia controversies: vasopressor choice for postspinal hypotension during cesarean delivery. Int Anesthesiol Clin, 2007;45:115-132.         [ Links ]

03. Saravanan S, Kocarev M, Wilson RC et al. - Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth, 2006;96:95-99.         [ Links ]

04. Hennebry MC, Stocks GM, Belavadi P et al. - Effect of i.v phenylephrine or ephedrine on the ED50 of intrathecal bupivacaine with fentanyl for Caesarean section. Br J Anaesth, 2009;102:806-811.         [ Links ]

05. Ngan Kee WD, Khaw KS - Vasopressors in obstetrics: what should we be using? Curr Opin Anaesthesiol, 2006;19:238-243.         [ Links ]

06. Prakash S, Pramanik V, Chellani H et al. - Maternal and neonatal effects of bolus administration of ephedrine and phenylephrine during spinal anaesthesia for caesarean delivery: a randomized study. Int J Obstet Anesth, 2010;19:24-30.         [ Links ]

07. Loughrey JPR, Yao N, Datta S et al. - Hemodynamic effects of spinal anesthesia and simultaneous intravenous bolus of combined phenylephrine and ephedrine versus ephedrine for cesarean delivery. Int J Obstet Anesth, 2005;14:43-47.         [ Links ]

08. Magalhães E, Govêia CS, Ladeira LCA et al. - Efedrina versus fenilefrina: prevenção de hipotensão arterial durante anestesia raquídea para cesariana e efeitos sobre o feto. Rev Bras Anestesiol, 2009;59:11-20.         [ Links ]

09. Siddik-Sayyid SM, Nasr VG, Taha SK et al. - A randomized trial comparing colloid preload to coload during spinal anesthesia for elective cesarean delivery. Anesth Analg, 2009;109:1219-1224.         [ Links ]

10. Ngan Kee WD, Khaw KS, Ng FF et al. - Prophylactic phenylephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery. Anesth Analg, 2004;98:815-821.         [ Links ]

11. Ngan Kee WD, Khaw KS, Tan PE et al. - Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology, 2009;111:506-512.         [ Links ]

12. Langesaeter E, Rosseland LA, Stubhaug A - Continuous invasive blood pressure and cardiac output monitoring during cesarean delivery: a randomized, double-blind comparison of low-dose versus highdose spinal anesthesia with intravenous phenylephrine or placebo infusion. Anesthesiology, 2008;109:856-863.         [ Links ]

13. Ngan Kee WD, Tam YH, Khaw KS et al. - Closed-loop feedback computer-controlled infusion of phenylephrine for maintaining blood pressure during spinal anaesthesia for caesarean section: a preliminary descriptive study. Anaesthesia, 2007;62:1251-1256.         [ Links ]

14. Dyer RA, Reed AR, van Dyk D et al. Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery. Anesthesiology, 2009;111:753-765.         [ Links ]

15. Slullitel A - Vasopressores. em: Cangiani LM, Posso IP, Potério GMB et al. Tratado de Anestesiologia SAESP, 6ª Ed, São Paulo, Atheneu, 2006;655-666.         [ Links ]

16. Erkinaro T, Kavasmaa T, Pakkila M et al. - Ephedrine and phenylephrine for the treatment of maternal hypotension in a chronic sheep model of increased placental vascular resistance. Br J Anaesth, 2006;96:231-237.         [ Links ]

 

 

Correspondence to:
Dra. Hellen Bedim Bonin
Rua Vicente Beghelli, 315 Dom Bosco
36025-550 - Juiz de Fora, MG
E-mail: helennbonin@hotmail.com

Submitted on November 9, 2009
Approved on March 24, 2010

 

 

Received from Hospital Monte Sinai, aggregate of CET/SBA of Universidade Federal de Juiz de Fora, MG